Physician profile
Michael Taba
NPI 1720024029
$2,543.89
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $539 · 2020: $10.27 · 2021: $158 · 2022: $1,608 · 2023: $229.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $229.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $229.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $1,554.19 | 2022 | |
| Stryker Corporation | $591.27 | 2019-2023 | Mako |
| Zimmer Biomet Holdings, INC. | $208.11 | 2021-2023 | |
| Pacira Pharmaceuticals Incorporated | $49.95 | 2019-2022 | |
| Pacira Therapeutics, INC. | $26.56 | 2021 | |
| Ermi LLC | $24.03 | 2019 | |
| Orthogenrx INC. | $19.92 | 2021 | |
| Heron Therapeutics, INC. | $18.62 | 2023 | Zynrelef |
| Depuy Synthes Sales INC. | $15.73 | 2022 | |
| Fidia Pharma USA INC. | $13.07 | 2023 | Triluron, Hymovis |
| Kowa Pharmaceuticals America, INC. | $12.17 | 2022 | |
| Orthofix Medical, INC. | $10.27 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Taba listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.